Research shows that deep brain stimulation may help boost energy levels in Parkinson’s brain cells by increasing the size of mitochondria.
The pioneering GDNF clinical trials programme delivered an experimental treatment directly to the brain. The trial results offer hope that it may be possible to restore the cells damaged in Parkinson’s.
Parkinson's UK is 1 of 24 members of the Association of Medical Research Charities that have worked in collaboration to develop and launch a new open publication platform – AMRC Open Research.
Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.
The groundbreaking clinical trial of GDNF, a potential treatment for Parkinson's, is now complete. Analysis of the results is now well underway and is expected to be published in February 2019.
We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
Researchers at the University of Edinburgh have used cutting-edge gene-editing techniques to create stem cells that are resistant to developing Parkinson’s.